Combined immunopositivity for Gal-3, CK19, and HBME-1 shows high sensitivity (95%) and specificity (97%) for the diagnosis of papillary thyroid carcinoma (11, 12, 58–64, 66, 68, 69) (Figure 6). The gene discussed is KRT19; the disease is thyroid gland papillary carcinoma.